| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.008 | 0.9 |